Candida-elicited murine TH17 cells express high CTLA-4 compared with th1 cells and are resistant to costimulation blockade

Journal of Immunology

Volumn 192, Issue 5, 2014, Pages 2495-2504

  Krummey, Scott M ^a   Floyd, Tamara L ^a   Liu, Danya ^a   Wagener, Maylene E ^a   Song, Mingqing ^a   Ford, Mandy L ^a  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CD28 ANTIGEN; CHEMOKINE RECEPTOR CCR6; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 17;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIGEN EXPRESSION; ARTICLE; CANDIDA ALBICANS; CELLULAR IMMUNITY; CONTROLLED STUDY; EX VIVO STUDY; GRAFT REJECTION; IMMUNOSTIMULATION; LYMPHOCYTE ACTIVATION; LYMPHOCYTE COUNT; MOUSE; MYCOBACTERIUM TUBERCULOSIS; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; SKIN GRAFT; TH1 CELL; TH17 CELL;

ANIMALS; ANTIGENS, BACTERIAL; ANTIGENS, FUNGAL; CANDIDA ALBICANS; CTLA-4 ANTIGEN; IMMUNIZATION; INTERFERON-GAMMA; MICE; MICE, TRANSGENIC; MYCOBACTERIUM TUBERCULOSIS; TH1 CELLS; TH17 CELLS;

EID: 84896523284     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1301332     Document Type: Article

References (59)

1. Sallusto, F., and A. Lanzavecchia. 2009. Heterogeneity of CD4+ memory T cells: functional modules for tailored immunity. Eur. J. Immunol. 39: 2076-2082.
2. Pepper, M., and M. K. Jenkins. 2011. Origins of CD4(+) effector and central memory T cells. Nat. Immunol. 12: 467-471.
3. Kaech, S. M., and W. Cui. 2012. Transcriptional control of effector and memory CD8+ T cell differentiation. Nat. Rev. Immunol. 12: 749-761.
4. Zielinski, C. E., D. Corti, F. Mele, D. Pinto, A. Lanzavecchia, and F. Sallusto. 2011. Dissecting the human immunologic memory for pathogens. Immunol. Rev. 240: 40-51.
5. Smith, C., J. J. Miles, and R. Khanna. 2012. Advances in direct T-cell alloreactivity: function, avidity, biophysics and structure. Am. J. Transplant. 12: 15-26.
6. Adams, A. B., T. C. Pearson, and C. P. Larsen. 2003. Heterologous immunity: an overlooked barrier to tolerance. Immunol. Rev. 196: 147-160.
7. Brehm, M. A., K. A. Daniels, B. Priyadharshini, T. B. Thornley, D. L. Greiner, A. A. Rossini, and R. M. Welsh. 2010. Allografts stimulate cross-reactive virusspecific memory CD8 T cells with private specificity. Am. J. Transplant. 10: 1738-1748.
8. Brehm, M. A., T. G. Markees, K. A. Daniels, D. L. Greiner, A. A. Rossini, and R. M. Welsh. 2003. Direct visualization of cross-reactive effector and memory allo-specific CD8 T cells generated in response to viral infections. J. Immunol. 170: 4077-4086.
9. Amir, A. L., L. J. D'Orsogna, D. L. Roelen, M. M. Van Loenen, R. S. Hagedoorn, R. De Boer, M. A. Van der Hoorn, M. G. Kester, I. I. Doxiadis, II, J. H. Falkenburg, et al. 2010. Allo-HLA reactivity of virus-specific memory T cells is common. Blood 115: 3146-3157.
10. Felix, N. J., and P. M. Allen. 2007. Specificity of T-cell alloreactivity. Nat. Rev. Immunol. 7: 942-953.
11. Felix, N. J., D. L. Donermeyer, S. Horvath, J. J. Walters, M. L. Gross, A. Suri, and P. M. Allen. 2007. Alloreactive T cells respond specifically to multiple distinct peptide-MHC complexes. Nat. Immunol. 8: 388-397.
12. Morris, G. P., P. P. Ni, and P. M. Allen. 2011. Alloreactivity is limited by the endogenous peptide repertoire. Proc. Natl. Acad. Sci. USA 108: 3695-3700.
13. Falkenburg,W. J., J. J. Melenhorst, M. Van De Meent, M. G. Kester, P. Hombrink, M. H. Heemskerk, R. S. Hagedoorn, E. Gostick, D. A. Price, J. H. Falkenburg, et al. 2011. Allogeneic HLA-A02-restricted WT1-specific T cells from mismatched donors are highly reactive but show off-target promiscuity. J. Immunol. 187: 2824-2833.
14. Adams, A. B., M. A. Williams, T. R. Jones, N. Shirasugi, M. M. Durham, S. M. Kaech, E. J. Wherry, T. Onami, J. G. Lanier, K. E. Kokko, et al. 2003. Heterologous immunity provides a potent barrier to transplantation tolerance. J. Clin. Invest. 111: 1887-1895.
15. Williams, M. A., T. M. Onami, A. B. Adams, M. M. Durham, T. C. Pearson, R. Ahmed, and C. P. Larsen. 2002. Cutting edge: persistent viral infection prevents tolerance induction and escapes immune control following CD28/CD40 blockade-based regimen. J. Immunol. 169: 5387-5391.
16. Socié, G., and B. R. Blazar. 2009. Acute graft-versus-host disease: from the bench to the bedside. Blood 114: 4327-4336.
17. Blazar, B. R., W. J. Murphy, and M. Abedi. 2012. Advances in graft-versus-host disease biology and therapy. Nat. Rev. Immunol. 12: 443-458.
18. Vincenti, F., G. Blancho, A. Durrbach, P. Friend, J. Grinyo, P. F. Halloran, J. Klempnauer, P. Lang, C. P. Larsen, F. Mühlbacher, et al. 2010. Five-year safety and efficacy of belatacept in renal transplantation. J. Am. Soc. Nephrol. 21: 1587-1596.
19. Ndejembi, M. P., J. R. Teijaro, D. S. Patke, A. W. Bingaman, M. R. Chandok, A. Azimzadeh, S. G. Nadler, and D. L. Farber. 2006. Control of memory CD4 T cell recall by the CD28/B7 costimulatory pathway. J. Immunol. 177: 7698-7706.
20. Benghiat, F. S., L. Craciun, V. De Wilde, T. Dernies, C. Kubjak, F. Lhomme, M. Goldman, and A. Le Moine. 2008. IL-17 production elicited by allo-major histocompatibility complex class II recognition depends on CD25posCD4pos T cells. Transplantation 85: 943-949.
21. Bouguermouh, S., G. Fortin, N. Baba, M. Rubio, and M. Sarfati. 2009. CD28 costimulation down regulates Th17 development. PLoS One 4: e5087.
22. deWit, J., Y. Souwer, A. J. Van Beelen, R. De Groot, F. J. Muller, H. Klaasse Bos, T. Jorritsma, M. L. Kapsenberg, E. C. De Jong, and S. M. Van Ham. 2011. CD5 costimulation induces stable Th17 development by promoting IL-23R expression and sustained STAT3 activation. Blood 118: 6107-6114.
23. Ying, H., L. Yang, G. Qiao, Z. Li, L. Zhang, F. Yin, D. Xie, and J. Zhang. 2010. Cutting edge: CTLA-4-B7 interaction suppresses Th17 cell differentiation. J. Immunol. 185: 1375-1378.
24. Santarlasci, V., L. Maggi, M. Capone, V. Querci, L. Beltrame, D. Cavalieri, E. D'Aiuto, R. Cimaz, A. Nebbioso, F. Liotta, et al. 2012. Rarity of human T helper 17 cells is due to retinoic acid orphan receptor-dependent mechanisms that limit their expansion. Immunity 36: 201-214.
25. Chatterjee, M., T. Rauen, K. Kis-Toth, V. C. Kyttaris, C. M. Hedrich, C. Terhorst, and G. C. Tsokos. 2012. Increased expression of SLAM receptors SLAMF3 and SLAMF6 in systemic lupus erythematosus T lymphocytes promotes Th17 differentiation. J. Immunol. 188: 1206-1212.
26. Paulos, C. M., C. Carpenito, G. Plesa, M. M. Suhoski, A. Varela-Rohena, T. N. Golovina, R. G. Carroll, J. L. Riley, and C. H. June. 2010. The inducible costimulator (ICOS) is critical for the development of human T(H)17 cells. Sci. Transl. Med. 2: 55ra78.
27. Linsley, P. S., and S. G. Nadler. 2009. The clinical utility of inhibiting CD28-mediated costimulation. Immunol. Rev. 229: 307-321.
28. Racke, M. K., D. E. Scott, L. Quigley, G. S. Gray, R. Abe, C. H. June, and P. J. Perrin. 1995. Distinct roles for B7-1 (CD-80) and B7-2 (CD-86) in the initiation of experimental allergic encephalomyelitis. J. Clin. Invest. 96: 2195-2203.
29. Sandborn, W. J., J. F. Colombel, B. E. Sands, P. Rutgeerts, S. R. Targan, R. Panaccione, B. Bressler, K. Geboes, S. Schreiber, R. Aranda, et al. 2012. Abatacept for Crohn's disease and ulcerative colitis. Gastroenterology 143: 62-69.e4.
30. Amezcua-Guerra, L. M., B. Hernández-Martínez, C. Pineda, and R. Bojalil. 2006. Ulcerative colitis during CTLA-4Ig therapy in a patient with rheumatoid arthritis. Gut 55: 1059-1060.
31. Floyd, T. L., B. H. Koehn, W. H. Kitchens, J. M. Robertson, J. A. Cheeseman, L. Stempora, C. P. Larsen, and M. L. Ford. 2011. Limiting the amount and duration of antigen exposure during priming increases memory T cell requirement for costimulation during recall. J. Immunol. 186: 2033-2041.
32. McGeachy, M. J., K. S. Bak-Jensen, Y. Chen, C. M. Tato, W. Blumenschein, T. McClanahan, and D. J. Cua. 2007. TGF-beta and IL-6 drive the production of IL-17 and IL-10 by T cells and restrain T(H)-17 cell-mediated pathology. Nat. Immunol. 8: 1390-1397.
33. Hirota, K., J. H. Duarte, M. Veldhoen, E. Hornsby, Y. Li, D. J. Cua, H. Ahlfors, C. Wilhelm, M. Tolaini, U. Menzel, et al. 2011. Fate mapping of IL-17-producing T cells in inflammatory responses. Nat. Immunol. 12: 255-263.
34. Infante-Duarte, C., H. F. Horton, M. C. Byrne, and T. Kamradt. 2000. Microbial lipopeptides induce the production of IL-17 in Th cells. J. Immunol. 165: 6107-6115.
35. McGeachy, M. J., Y. Chen, C. M. Tato, A. Laurence, B. Joyce-Shaikh, W. M. Blumenschein, T. K. McClanahan, J. J. O'Shea, and D. J. Cua. 2009. The interleukin 23 receptor is essential for the terminal differentiation of interleukin 17-producing effector T helper cells in vivo. Nat. Immunol. 10: 314-324.
36. Peters, A., Y. Lee, and V. K. Kuchroo. 2011. The many faces of Th17 cells. Curr. Opin. Immunol. 23: 702-706.
37. Esplugues, E., S. Huber, N. Gagliani, A. E. Hauser, T. Town, Y. Y. Wan, W. O'Connor, Jr., A. Rongvaux, N. Van Rooijen, A. M. Haberman, et al. 2011. Control of TH17 cells occurs in the small intestine. Nature 475: 514-518.
38. Lee, Y., A. Awasthi, N. Yosef, F. J. Quintana, S. Xiao, A. Peters, C. Wu, M. Kleinewietfeld, S. Kunder, D. A. Hafler, et al. 2012. Induction and molecular signature of pathogenic TH17 cells. Nat. Immunol. 13: 991-999.
39. Teft, W. A., M. G. Kirchhof, and J. Madrenas. 2006. A molecular perspective of CTLA-4 function. Annu. Rev. Immunol. 24: 65-97.
40. Alegre, M. L., K. A. Frauwirth, and C. B. Thompson. 2001. T-cell regulation by CD28 and CTLA-4. Nat. Rev. Immunol. 1: 220-228.
41. Walker, L. S., and D. M. Sansom. 2011. The emerging role of CTLA4 as a cellextrinsic regulator of T cell responses. Nat. Rev. Immunol. 11: 852-863.
42. Krummel, M. F., and J. P. Allison. 1995. CD28 and CTLA-4 have opposing effects on the response of T cells to stimulation. J. Exp. Med. 182: 459-465.
43. Roy, M., T. Waldschmidt, A. Aruffo, J. A. Ledbetter, and R. J. Noelle. 1993. The regulation of the expression of gp39, the CD40 ligand, on normal and cloned CD4+ T cells. J. Immunol. 151: 2497-2510.
44. Larsen, C. P., and T. C. Pearson. 1997. The CD40 pathway in allograft rejection, acceptance, and tolerance. Curr. Opin. Immunol. 9: 641-647.
45. Annunziato, F., L. Cosmi, V. Santarlasci, L. Maggi, F. Liotta, B. Mazzinghi, E. Parente, L. Filí, S. Ferri, F. Frosali, et al. 2007. Phenotypic and functional features of human Th17 cells. J. Exp. Med. 204: 1849-1861.
46. Ivanov, I. I., B. S. McKenzie, L. Zhou, C. E. Tadokoro, A. Lepelley, J. J. Lafaille, D. J. Cua, and D. R. Littman. 2006. The orphan nuclear receptor RORgammat directs the differentiation program of proinflammatory IL-17+ T helper cells. Cell 126: 1121-1133.
47. Hue, S., P. Ahern, S. Buonocore, M. C. Kullberg, D. J. Cua, B. S. McKenzie, F. Powrie, and K. J. Maloy. 2006. Interleukin-23 drives innate and T cellmediated intestinal inflammation. J. Exp. Med. 203: 2473-2483.
48. Awasthi, A., L. Riol-Blanco, A. Jäger, T. Korn, C. Pot, G. Galileos, E. Bettelli, V. K. Kuchroo, and M. Oukka. 2009. Cutting edge: IL-23 receptor gfp reporter mice reveal distinct populations of IL-17-producing cells. J. Immunol. 182: 5904-5908.
49. Cua, D. J., J. Sherlock, Y. Chen, C. A. Murphy, B. Joyce, B. Seymour, L. Lucian, W. To, S. Kwan, T. Churakova, et al. 2003. Interleukin-23 rather than interleukin-12 is the critical cytokine for autoimmune inflammation of the brain. Nature 421: 744-748.
50. Jäger, A., V. Dardalhon, R. A. Sobel, E. Bettelli, and V. K. Kuchroo. 2009. Th1, Th17, and Th9 effector cells induce experimental autoimmune encephalomyelitis with different pathological phenotypes. J. Immunol. 183: 7169-7177.
51. Corse, E., and J. P. Allison. 2012. Cutting edge: CTLA-4 on effector T cells inhibits in trans. J. Immunol. 189: 1123-1127.
52. Lu, Y., H. Schneider, and C. E. Rudd. 2012. Murine regulatory T cells differ from conventional T cells in resisting the CTLA-4 reversal of TCR stop-signal. Blood 120: 4560-4570.
53. Qureshi, O. S., Y. Zheng, K. Nakamura, K. Attridge, C. Manzotti, E. M. Schmidt, J. Baker, L. E. Jeffery, S. Kaur, Z. Briggs, et al. 2011. Transendocytosis of CD80 and CD86: a molecular basis for the cell-extrinsic function of CTLA-4. Science 332: 600-603.
54. Tai, X., F. Van Laethem, L. Pobezinsky, T. Guinter, S. O. Sharrow, A. Adams, L. Granger, M. Kruhlak, T. Lindsten, C. B. Thompson, et al. 2012. Basis of CTLA-4 function in regulatory and conventional CD4(+) T cells. Blood 119: 5155-5163.
55. Wang, C. J., R. Kenefeck, L. Wardzinski, K. Attridge, C. Manzotti, E. M. Schmidt, O. S. Qureshi, D. M. Sansom, and L. S. Walker. 2012. Cutting edge: cell-extrinsic immune regulation by CTLA-4 expressed on conventional T cells. J. Immunol. 189: 1118-1122.
56. Cosmi, L., R. De Palma, V. Santarlasci, L. Maggi, M. Capone, F. Frosali, G. Rodolico, V. Querci, G. Abbate, R. Angeli, et al. 2008. Human interleukin 17-producing cells originate from a CD161+CD4+ T cell precursor. J. Exp. Med. 205: 1903-1916.
57. Fábrega, E., M. López-Hoyos, D. San Segundo, F. Casafont, and F. Pons-Romero. 2009. Changes in the serum levels of interleukin-17/ interleukin-23 during acute rejection in liver transplantation. Liver Transpl. 15: 629-633.
58. Vanaudenaerde, B. M., L. J. Dupont, W. A. Wuyts, E. K. Verbeken, I. Meyts, D. M. Bullens, E. Dilissen, L. Luyts, D. E. Van Raemdonck, and G. M. Verleden. 2006. The role of interleukin-17 during acute rejection after lung transplantation. Eur. Respir. J. 27: 779-787.
59. Chung, B. H., K. W. Kim, I. O. Sun, S. R. Choi, H. S. Park, E. J. Jeon, B. M. Kim, B. S. Choi, C. W. Park, Y. S. Kim, et al. 2012. Increased interleukin-17 producing effector memory T cells in the end-stage renal disease patients. Immunol. Lett. 141: 181-189.